Short answer
Taysha Gene Therapies, Inc. (TSHA) filed an 8-K current report with the SEC on May 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Item 2.02 furnishes an 8-K and Exhibit 99.1 without Section 18 liability.
Taysha Gene Therapies, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 furnishes an 8-K and Exhibit 99.1 without Section 18 liability
- Exhibit 99.1 likely contains the fiscal-year results requiring review for financial figures and operating updates
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Taysha Gene Therapies, Inc. 8-K filings
Get the next TSHA 8-K as it lands
Follow TSHA for push alerts, or ask the research agent what this filing means.